Sexual Health Screening: Your Guide to 2026

You're often here for a very ordinary reason that suddenly feels loaded. A new partner. A condom that split. A text from someone saying they've tested positive. Or no drama at all, just that small question in the back of your mind asking whether you should check.

That's exactly what sexual health screening is for. It gives you a clear answer based on the right samples, taken at the right time, rather than on symptoms, guesswork, or reassurance from a recent conversation.

In England, this isn't a niche service. It's a routine part of public health. UKHSA reports that 8,903,930 STI tests were carried out in 2025, and 2,358,128 of those were sexual health screens for chlamydia, gonorrhoea, syphilis or HIV. That screen volume was almost unchanged from 2,368,291 in 2024, which shows a stable national baseline for screening even while diagnoses and service use shift year to year, according to the UKHSA 2025 STI and chlamydia screening report.

What Sexual Health Screening Actually Means

Sexual health screening is a set of tests used to check for sexually transmitted infections, whether you have symptoms or not. That distinction matters. Plenty of people search for a test because they've noticed discharge, bleeding, ulcers, burning, pelvic pain, or a rash. That's still important, but once symptoms are present, you're moving closer to diagnostic testing and clinical assessment, not just routine screening.

Screening is about finding what you can't feel

Many infections are quiet at first. They don't announce themselves. A person can feel completely well and still carry an infection in the genitals, throat, rectum, or blood.

That's why screening usually checks for several infections at once rather than only one. It also relies on laboratory testing, not visual inspection or self-diagnosis.

Practical rule: If your only reason for not testing is “I feel fine,” that isn't a reliable reason to wait.

It's not one test and it's not one sample

People often imagine a single “STI test”. In practice, a proper sexual health screen may include:

• A urine sample for some bacterial infections
• A vaginal, throat, or rectal swab depending on the type of sex you've had
• A blood sample for infections such as HIV, syphilis, and hepatitis

The point is early detection. When an infection is picked up early, treatment is usually simpler, partner notification is easier, and you're less likely to pass it on without realising.

A good screen answers practical questions. What infections are being checked? Which samples do you need? When is the right time to test after sex? Can an at-home kit do the job? When should you still go to an NHS sexual health clinic or GP? Those are the questions that make the process feel manageable.

The Main STIs Screened For in the UK

A standard UK sexual health screen usually focuses on six infections. Two are common bacterial STIs. Two are blood-borne viruses. One is a bacterial infection that can be subtle but serious if missed. One is another liver virus that matters in specific risk settings.

The infections most people are checked for

• Chlamydia
  A bacterial infection spread through vaginal, anal, or oral sex. It often causes no symptoms. If it's found, treatment is usually straightforward with antibiotics.

• Gonorrhoea
  Another bacterial infection spread in similar ways. It can infect the genitals, throat, or rectum. Some people notice discharge or pain, but many don't. A positive result leads to treatment and, at times, follow-up arranged through a clinic.

• HIV
  A virus that affects the immune system and is spread through certain body fluids. Early detection matters because people who start treatment promptly can live a normal life expectancy. A reactive screening result needs confirmatory laboratory follow-up.

• Syphilis
  A bacterial infection that may begin with a sore or a rash, but it can also be missed because symptoms can be mild or hidden. It's treatable, often with penicillin, but it can become dangerous if left untreated.

• Hepatitis B
  A virus that affects the liver. It can be spread sexually and through blood exposure. It's especially important because there is a vaccine, and a positive result changes what follow-up and partner advice are needed.

• Hepatitis C
  Another virus affecting the liver, more strongly associated with blood exposure but sometimes included when risk factors make it relevant. It's important because modern treatment can cure it.

Why these six matter in practice

These infections don't all behave the same way. Chlamydia and gonorrhoea often sit at the site of contact. HIV, syphilis, and hepatitis are usually picked up through blood testing. Syphilis deserves particular attention because missing it can have long-term consequences even when the first signs fade on their own.

England's screening system has expanded over time. Parliamentary research notes that sexual health screens in England rose from 1,513,288 in 2013 to 1,778,306 in 2017, an 18% increase, and the same briefing reports more than 1.5 million chlamydia tests among 15 to 24 year olds in 2015 with 129,022 diagnoses, as set out in the Parliamentary research briefing on sexual health services.

If you're choosing an at-home option, this is why product choice matters. Some people need a simple urine-and-blood kit. Others need extra throat or rectal sampling because of the kind of sex they've had.

Sample Types and How They Are Collected

No single sample catches every infection. That's the first point that clears up a lot of confusion. A urine pot can be useful, but it can't replace every swab or every blood test.

Urine, swabs, and blood do different jobs

For men, UK guidance uses first-void urine for Chlamydia trachomatis and Neisseria gonorrhoeae NAAT testing. For women, a self-taken vulvovaginal swab is commonly used for dual NAAT testing. In men who have sex with men, pharyngeal and rectal dual-NAAT swabs are also recommended because infections at those sites would otherwise be missed, according to NHS Borders sexual health clinical guidance.

Checking rooms in a house after a leak. If water entered through the kitchen ceiling, only inspecting the hallway won't tell you much. Infections tend to be found where sexual contact happened.

Infection	Primary sample	Other possible samples
Chlamydia	Urine or vaginal swab	Throat swab, rectal swab
Gonorrhoea	Urine or vaginal swab	Throat swab, rectal swab
HIV	Blood sample	None routinely for screening
Syphilis	Blood sample	Swab from a sore in clinical settings
Hepatitis B	Blood sample	None routinely for screening
Hepatitis C	Blood sample	None routinely for screening

What the collection process usually feels like

• Urine sample: This is usually a first-catch sample. You don't need a large amount.
• Vaginal swab: Often self-taken. Many find it more straightforward than they expected.
• Throat swab: Quick, slightly awkward, usually over in seconds.
• Rectal swab: Also self-taken in many pathways, with clear instructions.
• Finger-prick or venous blood: Used for HIV, syphilis, and hepatitis screening.

If you're comparing kits, the useful question isn't “Which test is easiest?” It's “Which test matches where exposure happened?” That's where products such as a self-swab testing kit become relevant, because some screening pathways depend on the right swab site rather than on a one-size-fits-all sample.

Who Should Get Tested and How Often

Testing frequency isn't meant to be moral. It's practical. The more often your circumstances change, the more often your testing schedule should change too.

The basic UK pattern

Current UK guidance says sexually active people should generally test annually and after partner change, with a maximum testing frequency of every 3 months. Higher-risk groups, including PrEP users, people with more than 10 partners in the last 12 months, or those with multiple or anonymous partners since the last STI test, are recommended to test every 3 months, according to the BASHH summary guidance on STI testing 2023.

English chlamydia screening standards also recommend testing at partner change, or annually if there has been no partner change, and re-testing after treatment should take place 3 to 6 months later, as set out in the NCSP standards eighth edition.

Timing matters as much as frequency

A test is only useful if enough time has passed for it to detect infection. UK guidance gives these window periods:

• Chlamydia and gonorrhoea from 2 weeks after sexual contact
• HIV from 7 weeks
• Syphilis and hepatitis B from 12 weeks
• Hepatitis C from 6 months

Those timings come from Newcastle Hospitals sexual health screening guidance.

If you test too early, a negative result may only mean the test was early, not that nothing happened.

Matching the advice to real life

Here's a simple way to approach it:

• New relationship: test before stopping condoms or early in the relationship.
• Condom break or unplanned exposure: mark the date, then test at the correct window period.
• Multiple or changing partners: don't rely on a yearly diary reminder. Build in more regular screening.
• Symptoms: don't wait for a home kit if you have pain, ulcers, bleeding, or feel unwell. Go to a clinic or GP.
• Pregnancy planning: screening is sensible before trying and during pregnancy when advised.

In many services, this planning work is handled before the sample is even taken. That's why clinics and digital pathways often rely on structured triage, and why a role such as a patient intake coordinator matters operationally. Good intake questions help match the right person to the right test at the right time.

How At-Home Screening Works with Repose Healthcare

At-home screening works best when you treat it as part of healthcare, not as a shortcut around it. It can save time and protect privacy, but it still depends on proper kit choice, careful sample collection, and follow-up if a result needs action.

What the process looks like at home

A typical pathway starts with choosing a test based on your exposure. If you've had vaginal sex only, you may need a different kit than someone who also needs throat or rectal testing. If blood-borne infections are relevant, the kit also needs a blood component.

From there, the steps are usually simple:

1. Choose a suitable panel based on symptoms, site of exposure, or routine screening needs.
2. Order online and wait for the kit to arrive in discreet packaging.
3. Collect the sample using the instructions provided. That may include urine, a swab, a finger-prick blood sample, or a combination.
4. Register or activate the kit using its ID so the laboratory can match your sample correctly.
5. Seal and return it using prepaid packaging.
6. Check results securely online once the laboratory has processed the sample.

Where it fits alongside NHS care

Repose Healthcare offers online laboratory tests in the UK that follow this kind of pathway, with prepaid returns and secure result reporting. Used properly, an at-home service can be a practical option for routine screening, partner-change testing, or people who want privacy and a clear process.

At-home testing doesn't replace a clinic when you need examination, urgent treatment, vaccination, or in-person review. It sits alongside NHS sexual health care.

That matters because testing patterns are changing. UKHSA reports that HIV testing in all sexual health services rose 3% since 2023 to 1.32 million tests in 2024, while 183,876 HIV tests were done in participating GP practices in 2024, up 18.4% from 2023 and 80% from 2019, showing a shift toward primary-care-based testing. The same report notes women tested in sexual health services were still 8% below 2019 levels despite a 2% year-on-year increase, and that positivity in sexual health services was 0.06% in 2024, according to the UKHSA Understanding HIV Testing in England 2025 report.

Reading Your Results and Next Steps

Results usually fall into three broad groups: negative, positive or reactive, and inconclusive. The words matter, because each one tells you something different.

What each result actually means

Result type	What it means	Recommended next step
Negative	No infection was detected in the samples taken	Check whether you tested after the correct window period. Retest later if exposure was recent
Positive or reactive	The screen has found a result that needs treatment or further confirmation, depending on the infection	Follow the clinical advice promptly. Avoid sex until you've been told it's safe
Inconclusive	The lab couldn't give a clear answer, often because of sample quality or timing	Repeat the test or attend a clinic if advised

A negative result is reassuring, but only if the timing and sample sites were right. If you did a urine sample after oral or anal exposure, that doesn't tell you what was happening in the throat or rectum. If you tested too soon after sex, it may also be too early for detection.

What to do after a positive or reactive result

The first concern is often, “What happens now?” Usually, the next steps are practical:

• Get treatment arranged if it's a bacterial infection.
• Pause sexual contact until treatment is complete and any advice about clearance has been followed.
• Tell recent partners, either directly or through confidential notification support.
• Book any follow-up test you've been advised to do.

A result is useful only if it changes what you do next. Testing is the beginning of the decision, not the whole decision.

If you're unsure how long results usually take or what happens once the lab has your sample, a guide to STI test result timing can help you understand the process before you start chasing the portal.

For chlamydia screening in England, re-testing after treatment is recommended 3 to 6 months later, as noted earlier in the national standards. If symptoms continue despite a negative result, that also changes the plan. At that point, you need an examination and broader assessment rather than repeated self-testing.

Common Misconceptions About Screening

Most delays happen because of a false assumption, not because testing is difficult. Once you clear up the myths, the decision gets easier.

Four ideas that trip people up

“I'd know if I had something.”
Often you wouldn't. In England, among women aged 15 to 24 in the National Chlamydia Screening Programme, 547,308 tests were completed in 2025, down from 604,143 in 2024. Diagnoses fell from 53,408 to 46,122, while positivity shifted only slightly from 8.8% to 8.4%. That pattern suggests changes in screening coverage and case detection even when positivity stays broadly steady, according to the UKHSA annual STI and chlamydia screening report for 2025. In plain language, people don't stop needing screening just because symptoms aren't obvious.

“One urine sample covers everything.”
It doesn't. Site-specific infection is a real issue. If exposure happened in the throat or rectum, a genital sample can miss it.

“If my partner tested negative, I'm clear.”
Not necessarily. Timing matters. A recent test may have been done inside the window period, or it may not have included all relevant sites.

“Home testing replaces a clinic.”
Home screening is useful, but it can't perform a physical examination, give an urgent injection, look at a rash, or manage severe symptoms in real time.

A more useful way to think about it

• Screening finds silent infection before it causes trouble or spreads on.
• Correct sample sites matter as much as the test itself.
• Window periods matter as much as urgency.
• Clinics still matter when symptoms, treatment, vaccination, or partner care need hands-on support.

England's provisional Q1 2026 surveillance reported 13,529 gonorrhoea diagnoses and 1,721 infectious syphilis diagnoses at sexual health services, showing continued transmission pressure and supporting targeted repeat testing in higher-risk groups, according to the Health Protection Report volume 20 issue 5.

Putting It All Into a Simple Action Plan

When people feel stuck, it's usually because they're trying to answer too many questions at once. A simpler approach is to match your situation to the next sensible action.

Start with the situation you're in

• You've started seeing someone new
  Book a routine screen before deciding condoms are no longer needed. If exposure has already happened, test after the right window period.

• A condom broke or sex wasn't planned
  Write down the date. Then count forward before testing so the result means something.

• You have more than one partner, or partners change
  Move from occasional testing to regular screening. If you're in a higher-risk group, every 3 months may be appropriate under UK guidance.

• You have symptoms
  Don't rely only on an at-home pathway. Get assessed in person.

• You're doing an annual check
  Treat it like any other routine health job. Pick a date and do it.

Then match the samples to the exposure

Your test choice usually follows this logic:

• Genital exposure: chlamydia and gonorrhoea NAAT with urine or vaginal swab
• Blood-borne screening: HIV, syphilis, and hepatitis B or C when indicated
• Oral exposure: add a throat swab
• Anal exposure: add a rectal swab

The right test is the one that matches both the infection and the body site involved.

Four practical steps you can take today

1. Choose a kit or clinic pathway that matches your exposure and timing.
2. Take the sample carefully and follow the instructions exactly.
3. Return it promptly so delays don't complicate the timing.
4. Act on the result, whether that means reassurance, repeat testing, treatment, or clinic review.

If there's been a recent risk, or if you were treated for certain infections, build in repeat screening rather than treating one negative result as the end of the story. A practical next step is to compare the available sexual health panels and choose one that matches the kind of sex you've had, not just the label on the box.

---

Repose Healthcare offers private at-home sexual health testing with sample kits, prepaid returns, and secure online results, which can be useful when you want a structured screening pathway from home. If you want to compare options for routine checks, post-exposure testing, or broader sexual health panels, visit Repose Healthcare and choose a kit that fits your exposure, timing, and follow-up needs.